BIOLOTEGACC — MERGEN RESEARCH SRL (Q2023771)
Jump to navigation
Jump to search
Project Q2023771 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BIOLOTEGACC — MERGEN RESEARCH SRL |
Project Q2023771 in Italy |
Statements
467,854.94 Euro
0 references
623,806.6 Euro
0 references
75.0 percent
0 references
22 October 2017
0 references
16 October 2019
0 references
ISTITUTO NAZIONALE TUMORI IRCCS FONDAZIONE SENATORE G. PASCALE
0 references
MERIGEN RESEARCH SOCIETA' A RESPONSABILITA' LIMITATA
0 references
40°50'9.35"N, 14°14'55.61"E
0 references
BIOMOLTEACC - MERIGEN RESEARCH SRL - PROGETTI TRASFERIMENTO TECNOLOGICO E DI PRIMA INDUSTRIALIZZAZIONE PER LE IMPRESE INNOVATIVE AD ALTO POTENZIALE PER LA LOTTA ALLE PATOLOGIE ONCOLOGICHE (Italian)
0 references
BIOLEDACC — MERGEN RESEARCH SRL — TECHNOLOGY TRANSFER AND FIRST INDUSTRIALISATION PROJECTS FOR INNOVATIVE HIGH-POTENTIAL COMPANIES TO FIGHT CANCER DISEASES (English)
0 references
BIOMOLTEACC — RECHERCHE MERIGEN SRL — TRANSFERT DE TECHNOLOGIE ET PREMIERS PROJETS D’INDUSTRIALISATION POUR LES ENTREPRISES INNOVANTES À FORT POTENTIEL DE LUTTE CONTRE LES MALADIES CANCÉREUSES (French)
14 December 2021
0 references
BIOMOLTEACC — MERIGEN ONDERZOEK SRL — TECHNOLOGIEOVERDRACHT EN EERSTE INDUSTRIALISATIEPROJECTEN VOOR INNOVATIEVE BEDRIJVEN MET EEN HOOG POTENTIEEL VOOR DE BESTRIJDING VAN KANKERZIEKTEN (Dutch)
23 December 2021
0 references
BIOMOLTEACC – MERIGEN RESEARCH SRL – TECHNOLOGIETRANSFER UND ERSTE INDUSTRIALISIERUNGSPROJEKTE FÜR INNOVATIVE UNTERNEHMEN MIT HOHEM POTENZIAL ZUR BEKÄMPFUNG VON KREBSERKRANKUNGEN (German)
24 December 2021
0 references
BIOMOLTEACC — MERIGEN RESEARCH SRL — TRANSFERENCIA DE TECNOLOGÍA Y PRIMEROS PROYECTOS DE INDUSTRIALIZACIÓN PARA EMPRESAS INNOVADORAS CON ALTO POTENCIAL PARA LA LUCHA CONTRA LAS ENFERMEDADES CANCERÍGENAS (Spanish)
24 January 2022
0 references
NAPOLI
0 references
Identifiers
B63D18000220007
0 references